Tiruchi Corporation speeds up construction of urban health centres
The move comes in response to increasing public patronage of UPHCs in recent years, particularly during the COVID-19 pandemic, which exposed the urgent need to expand public health infrastructure.
Officials said the new centres were expected to ease pressure on existing facilities and offer hassle-free access to essential medical services, particularly for economically weaker sections.
Under the National Urban Health Mission (NUHM), the scheme envisions establishing one UPHC for every 50,000 people. With a population of 12 lakh, Tiruchi requires 24 UPHCs to ensure adequate healthcare coverage. At present, the city has 18 UPHCs and 36 health and wellness centres.
Several new UPHCs are under construction, while existing centres are being renovated and expanded. A new facility is being built at Panjapur with provision for inpatient facility, consultation rooms, and labs. The centre is aimed at covering low-income groups in the locality. Similarly, new facilities are being constructed at Lakshmi Nagar in Srirangam, Kongu Nagar in Ariyamangalam and Pappakurichi in Kattur at ₹1.20 crore each. New UPHCs are being established at Erikarai Main Road in Subramaniyapuram and Beerangikulam at a cost of ₹1.50 crore each.
Construction of additional buildings for the UPHCs is underway in Pappakurichi, Teppakulam, and Beemanagar areas, with an outlay of ₹60 lakh each. Similarly, urban health sub-centres are being established at Thiruvanaikovil, Ariyamangalam, and Khajamalai at a cost of ₹30 lakh each.
Meanwhile, urban health sub-centres at K.K. Nagar, Pandamangalam, Rail Nagar, Melur, JJ Nagar, Malai Kovil and Edamalaipattipudur, which were built at a cost of ₹30 lakh each, and additional buildings for the Thennur UPHC are ready for inauguration.
'The construction work is progressing at a brisk pace, and work at several sub-health centres is at finishing stages and is expected to be completed within two months,' said M. Vijay Chandran, City Health Officer.
The new centres are being set up in the city under the National Urban Health Mission with financial assistance from the Central and State governments.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
Aarthi Scans to invest Rs 350 crore, expand strongly in North India by 2030
Chennai-based Aarthi Scans and Labs, a leading diagnostic imaging services provider in South India, is preparing to aggressively expand its presence in the North Indian market. The company plans to add 90 per cent of its upcoming centres in the region by 2030. As part of this expansion, it will invest around Rs 350 crore to increase its total number of branches from 85 to around 150 over the next five years. Now in its 25th year of operations, Aarthi Scans is also planning to launch an initial public offering (IPO) within the next three years. Simultaneously, the company is preparing to foray into the fitness diagnostics segment to cater to a wider audience. 'We are planning our IPO in the next three years. Every year, we are clocking a growth of around 20 per cent. In FY25, our turnover was around Rs 320 crore, which is slated to cross Rs 375 crore during the current financial year,' said V Govindarajan, founder of Aarthi Scans and Labs. The company has set a target of achieving a turnover of Rs 600 crore in the next four to five years. Pan-India footprint with a northern focus Aarthi Scans currently operates 85 branches and 150 collection centres across 18 cities in 11 states, including Tamil Nadu, Karnataka, Telangana, Maharashtra, Delhi, West Bengal, Gujarat, Puducherry, Andhra Pradesh, Kerala, and Haryana. Around 25 branches are located in Chennai alone, with 18 clustered in and around the city. 'Our aim is to add an average of around 10 branches every year. Within three months, we will be starting operations in Uttar Pradesh as well. Of the total branch expansions in the next five years, 90 per cent will be in North India,' Govindarajan said. From outpatient clinic to diagnostic leader Govindarajan entered the healthcare sector in the late 1980s by starting a small clinic, Aarthi Clinic—named after his daughter—for his doctor wife in Kovilpatti, Tamil Nadu. The family launched a multispeciality hospital in 1995, followed by a foray into diagnostics in 2000 and the opening of its first centre in Chennai's Vadapalani in 2003. Today, Aarthi Scans is managed by a family-run team of radiologists: Prasanna Vignesh, Aarthi Prasanna, and Arunkumar Govindarajan. AI-led transformation and new service verticals Arunkumar, Govindarajan's son, is spearheading the company's technological transformation. From X-rays and CT scans to brain volumetric analysis, the company has adopted artificial intelligence (AI) across several operations. 'AI is making the job of radiologists easier. Globally too, India has adopted AI better than even some developed nations,' said Arunkumar. He added that the company is in the process of launching fitness diagnostics, a fast-growing segment in India. Private equity talks and future outlook Aarthi Scans came into the spotlight in 2022 when reports emerged that Tata Capital Growth Fund, a mid-market private equity fund, was in talks to acquire a minority stake in the company. 'We were in talks with Tata Capital during Covid. We were doing some extremely good business and wanted to rope in a minority investor. Finally, the valuation did not match,' Govindarajan said.
&w=3840&q=100)
Business Standard
5 hours ago
- Business Standard
Blood donation guide: Eligibility, myths, medications, and safety tips
If you're between 18 and 60 years old, weigh at least 45 kg, and have a haemoglobin level above 12.5 grams per decilitre (g/dL), you are eligible to donate blood in India. Men can donate blood every three months, while women should wait four months between donations. However, not everyone qualifies. Dr Amita Mahajan, Senior Consultant at Indraprastha Apollo Hospitals, explained that people with chronic illnesses like heart disease, cancer, and certain infections are typically not eligible. Those on specific medications—such as antibiotics, blood thinners, or chemotherapy drugs—may also need to defer donation. Smokers and those with tattoos can still donate. Just ensure the tattoo was done at a certified centre (or wait one year if it wasn't). Also, avoid alcohol for at least 12 hours before donating. Does blood donation make you weak? This is one of the most common myths. 'There's no weakness. It's only in the mind,' said Dr Krishna Kumar Rai, Head of Emergency Medicine at Fortis Escorts Hospital, Faridabad. Dr Amita Mahajan added, 'Your body replenishes the donated blood within days. There's no long-term impact on your strength or immunity.' The key is to stay hydrated, have a light meal beforehand, and avoid strenuous activity for a few hours afterward. Is blood donation safe? Yes, blood donation is completely safe when done at certified blood banks and hospitals. According to Dr Rahul Bhargava, Principal Director at Fortis Memorial Research Institute, donors might feel mild fatigue or light-headedness briefly, but serious complications are extremely rare. Modern practices ensure safety through strict hygiene and single-use sterile needles. For recipients, risks of transfusion-related infections like HIV or Hepatitis have significantly reduced due to advanced screening protocols. Can you donate blood if you are on medication? It depends. Dr Sangeeta Agarwal, Director of Transfusion Medicine at Fortis Memorial Research Institute, said that people taking vitamins or managing controlled blood pressure or diabetes (without insulin) can usually donate. However, if you're on antibiotics, steroids, antidepressants, chemotherapy drugs, or blood thinners, it's best to consult a doctor. Always disclose all medications to the blood bank team during pre-screening—they'll guide you accordingly. Can women safely donate blood? Yes, women can and should donate blood. There are no gender-based restrictions. However, they should avoid donating during menstruation and wait four months between donations. 'Women are often wrongly discouraged from donating blood,' said Dr Rai. 'The truth is, women's bodies are just as capable of handling blood donation as men's.' Can you donate blood after recovering from Covid-19? Yes. If you've recovered from Covid-19 and are feeling well, you are eligible to donate blood. Dr Rai stressed that there is no stigma or risk of transmitting Covid-19 through blood donation. 'If you're fully recovered, you're welcome to donate and save lives,' he said. How should you prepare before donating blood? Here's a simple checklist: Stay well-hydrated Eat light, healthy food about an hour before Avoid alcohol for at least 12 hours prior Skip heavy workouts before and after donation Avoid smoking two hours before and after donating Carry a valid ID and disclose any medications to the medical staff What are the benefits of donating blood? Besides saving lives, blood donation offers emotional and potential health rewards. 'It's like a noble high,' said Dr Rai, who donates every year on his birthday. Some studies suggest that regular donors may enjoy improved heart health and reduced oxidative stress. Above all, it fosters a sense of purpose. 'Every healthy person eligible should donate,' said Dr Sangeeta Agarwal. 'You never know whose life you could save—your friend, a stranger, or a colleague. Blood banks only work when we all pitch in.'
Indian Express
9 hours ago
- Indian Express
ICMR invites partners to launch and sell its new malaria vaccine
The Indian Council of Medical Research (ICMR) has invited the country's vaccine manufacturers to partner with it to launch and sell a malaria vaccine that its Regional Medical Research Centre, Bhubaneshwar, has developed. Called AdFalciVax, it is a recombinant vaccine, meaning parts of the genes that encode for targets are inserted into a cell, the target proteins are expressed, and then used to trigger an immune response. Malaria is a parasitic infection transmitted by mosquitoes. While the current vaccine protects against the most common one that causes infection in humans called plasmodium falciparum, there are at least four other parasites from the same family known to cause infection in humans. P. vivax is the other one that commonly causes malaria infections, especially in India. The others — p malariae, p ovale, and p knowlesi — cause fewer infections. While the pre-clinical studies have already shown positive indications, the company that collaborates with the ICMR will be responsible for further development, human clinical trials, and scale-up for commercial production. The vaccine contains the genetic material of two targets — one for a major protein called CSP found on the surface of the malaria parasite and another for a combination of parts of two proteins that affect the pathogen's lifecycle. 'There are some key differences in the ICMR vaccine as compared to the other two currently in the market. One, this vaccine used the DNA for the whole CSP protein instead of just a few parts, meaning it is likely to produce a stronger immune response. Two, the other target that is used prevents the development of the p. falciparum in the mosquito's midgut during its lifecycle. What this essentially means is that it prevents the infection not only in the vaccinated person, but stops the further spread of the disease by disrupting the lifecycle of the pathogen even when it has already been picked up by a mosquito from an infected person for further transmission,' said Dr Subhash Singh, project manager for development of the vaccine. Senior scientist Dr Susheel Singh and director Dr Sanghamitra Pati were part of the development process. The pre-clinical validation was done in collaboration with ICMR-National Institute of Medical Research and the National Institute of Immunology. Anonna Dutt is a Principal Correspondent who writes primarily on health at the Indian Express. She reports on myriad topics ranging from the growing burden of non-communicable diseases such as diabetes and hypertension to the problems with pervasive infectious conditions. She reported on the government's management of the Covid-19 pandemic and closely followed the vaccination programme. Her stories have resulted in the city government investing in high-end tests for the poor and acknowledging errors in their official reports. Dutt also takes a keen interest in the country's space programme and has written on key missions like Chandrayaan 2 and 3, Aditya L1, and Gaganyaan. She was among the first batch of eleven media fellows with RBM Partnership to End Malaria. She was also selected to participate in the short-term programme on early childhood reporting at Columbia University's Dart Centre. Dutt has a Bachelor's Degree from the Symbiosis Institute of Media and Communication, Pune and a PG Diploma from the Asian College of Journalism, Chennai. She started her reporting career with the Hindustan Times. When not at work, she tries to appease the Duolingo owl with her French skills and sometimes takes to the dance floor. ... Read More
